DXR - צמיחת רווח למניה משנה לשנה בשנים עשר החודשים האחרונים Daxor Corporation

The slow adoption of BVA-100 in clinics is constraining margins, yet the quarterly EPS change scale demonstrates the resilience of Daxor Corporation (DXR). Software integration into cardiology creates strong customer lock-in, while the careful transportation of devices ensures diagnostic accuracy. The -790.20 level captures the current state of profit, allowing investors to assess real EPS dynamics without market noise and avoid overpaying at the peak.
פילוחי נתונים אנליטיים מרוכזים עבור daxor.com (DXR)

Daxor Corporation investments in energy efficiency and medical waste recycling directly impact operating margins, which is reflected in the earnings per share trend. This metric measures the rate of change in quarterly net income, allowing for the identification of abnormal deviations of the market price from the business's intrinsic value through the comparison of quarterly EPS and the timely recognition of artificial price inflation.